Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date	Form	Description	View
Jan 09, 2023	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001415889-23-000697.pdf 0001415889-23-000697.rtf 0001415889-23-000697.xls
May 01, 2015	3/A	An amendment to a 3 filing. Non-EDGAR filing	View HTML 0001104659-15-033273.pdf 0001104659-15-033273.rtf 0001104659-15-033273.xls
Mar 28, 2016	3/A	An amendment to a 3 filing. Non-EDGAR filing	View HTML 0001179110-16-022254.pdf 0001179110-16-022254.rtf 0001179110-16-022254.xls
Mar 31, 2022	3/A	An amendment to a 3 filing. Non-EDGAR filing	View HTML 0001415889-22-003505.pdf 0001415889-22-003505.rtf 0001415889-22-003505.xls
May 07, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0000315066-15-002590.pdf 0000315066-15-002590.rtf 0000315066-15-002590.xls
May 12, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0001012975-15-000330.pdf 0001012975-15-000330.rtf 0001012975-15-000330.xls
Nov 04, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-014505.pdf 0001179110-15-014505.rtf 0001179110-15-014505.xls
Nov 04, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-014506.pdf 0001179110-15-014506.rtf 0001179110-15-014506.xls
Nov 12, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-15-014787.pdf 0001179110-15-014787.rtf 0001179110-15-014787.xls
Nov 17, 2015	4	Statement of changes in beneficial ownership of securities	View HTML 0000315066-15-003307.pdf 0000315066-15-003307.rtf 0000315066-15-003307.xls

Continue